logo
Products
Technologies
Applications
Services
Resources
Selection Guides
About
Dual specificity protein kinase CLK4 Inhibitors (IC50, Ki)
Structure
Compound Name
Standard Type
Standard Values (in nM)
6-(1,3-Benzodioxol-5-yl)-N-(thiophen-2-ylmethyl)-4-quinazolinamineIC5039.0 [1], 63.0 [2]
CID 46926514IC5068.0 [1], 130.0 [2]
6-(3-Methoxyphenyl)-N-(thiophen-2-ylmethyl)-4-quinazolinamineIC50891.0 [1], 1051.0 [2]
6-(2,3-Dihydro-1,4-benzodioxin-6-yl)-N-(thiophen-2-ylmethyl)-4-quinazolinamineIC50126.0 [1], 141.0 [2]
6-(Furan-2-yl)-N-(thiophen-2-ylmethyl)quinazolin-4-amineIC50250.0 [1], 1090.0 [2]

References
This online resource may be cited as follows
MLA
"Quest DatabaseDual specificity protein kinase CLK4 Inhibitors (IC50, Ki)." AAT Bioquest, Inc.14 Nov2025https://www.aatbio.com/data-sets/dual-specificity-protein-kinase-clk4-inhibitors-ic50-ki.
APA
AAT Bioquest, Inc. (2025November 14). Quest DatabaseDual specificity protein kinase CLK4 Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/dual-specificity-protein-kinase-clk4-inhibitors-ic50-ki.
BibTeXEndNoteRefMan